Investing.com - Financial Markets Worldwide

Panacea Biotec Ltd (PNCA)

NSE
Symbol
Exchange
Currency
PNCA·NSE·INR
PNCA·BSE·INR
Currency in INR
407.10
-3.50(-0.85%)
Closed·
PNCA Scorecard
Full Analysis
Prominent player in the Biotechnology industry
PNCA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
407.10424.70
52 wk Range
133.47581.90
Key Statistics
Edit
Bid/Ask
407.10 / 409.45
Prev. Close
410.6
Open
411.5
Day's Range
407.1-424.7
52 wk Range
133.47-581.9
Volume
117.54K
Average Volume (3m)
204.87K
1-Year Change
204.8%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PNCA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 5
High return over the last year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Panacea Biotec Ltd Company Profile

Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Formulations segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as transplantation, renal disease, oncology, respiratory, pain management, diabetes and cardiovascular management, gastro-intestinal care, nephrology, osteoporosis management, orthopedics, pain management, and fever; and betacoronavirus, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, hepatitis A, and varicella vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V; Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc for the manufacture and supply of Azacitidine injection; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
1936
Market
India

Compare PNCA to Peers and Sector

Metrics to compare
PNCA
Peers
Sector
Relationship
P/E Ratio
−300.5x32.0x−0.5x
PEG Ratio
0.490.770.00
Price/Book
3.0x5.2x2.6x
Price / LTM Sales
4.5x4.4x3.3x
Upside (Analyst Target)
-13.6%43.4%
Fair Value Upside
Unlock1.5%7.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.31 / --
Revenue / Forecast
1.33B / --
EPS Revisions
a
a
Unlock
Last 90 days

PNCA Income Statement

People Also Watch

Jash Eng
519.85
JSHE
-0.12%
Vijaya Diagnostic Centre
1,050.90
VIJA
-0.68%
Apollo Hospitals
7,099.00
APLH
-0.99%
Glenmark Pharma
2,022.10
GLEN
-1.97%
Aditya Birla Capital
271.10
ADTB
-2.53%

FAQ

What Stock Exchange Does Panacea Biotec Trade On?

Panacea Biotec is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Panacea Biotec?

The stock symbol for Panacea Biotec is "PNCA."

What Is the Panacea Biotec Market Cap?

As of today, Panacea Biotec market cap is 25.02B.

What Is Panacea Biotec's Earnings Per Share (TTM)?

The Panacea Biotec EPS (TTM) is -1.37.

From a Technical Analysis Perspective, Is PNCA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Panacea Biotec Stock Split?

Panacea Biotec has split 0 times.

How Many Employees Does Panacea Biotec Have?

Panacea Biotec has 1936 employees.

What is the current trading status of Panacea Biotec (PNCA)?

As of 08 Aug 2025, Panacea Biotec (PNCA) is trading at a price of 407.10, with a previous close of 410.60. The stock has fluctuated within a day range of 407.10 to 424.70, while its 52-week range spans from 133.47 to 581.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.